FDA OKs new Johnson & Johnson schizophrenia drug

12/21/2006 | USA Today

The FDA approved Johnson & Johnson's schizophrenia drug Invega, or paliperidone, which is derived from the drug risperidone, sold under the brand name Risperdal. Invega will be sold in extended-release tablet form. The price was not released.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care